Logo image of CROS.PA

CROSSWOOD (CROS.PA) Stock Fundamental Analysis

EPA:CROS - FR0000050395 - Common Stock

10.7 EUR
+0.1 (+0.94%)
Last: 8/19/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, CROS scores 4 out of 10 in our fundamental rating. CROS was compared to 70 industry peers in the Real Estate Management & Development industry. CROS has an excellent financial health rating, but there are some minor concerns on its profitability. CROS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CROS was profitable.
CROS had a positive operating cash flow in the past year.
CROS had positive earnings in 4 of the past 5 years.
Of the past 5 years CROS 4 years had a positive operating cash flow.
CROS.PA Yearly Net Income VS EBIT VS OCF VS FCFCROS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

CROS has a better Return On Assets (5.39%) than 89.86% of its industry peers.
Looking at the Return On Equity, with a value of 6.53%, CROS is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.22%, CROS is doing worse than 62.32% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CROS is below the industry average of 4.15%.
Industry RankSector Rank
ROA 5.39%
ROE 6.53%
ROIC 0.22%
ROA(3y)3.13%
ROA(5y)5.13%
ROE(3y)3.87%
ROE(5y)6.65%
ROIC(3y)0.42%
ROIC(5y)0.55%
CROS.PA Yearly ROA, ROE, ROICCROS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8 10

1.3 Margins

With an excellent Profit Margin value of 615.20%, CROS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CROS's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 29.62%, CROS perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
In the last couple of years the Operating Margin of CROS has declined.
CROS's Gross Margin of 65.77% is in line compared to the rest of the industry. CROS outperforms 56.52% of its industry peers.
CROS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 29.62%
PM (TTM) 615.2%
GM 65.77%
OM growth 3Y-15.69%
OM growth 5Y-19.63%
PM growth 3Y0.74%
PM growth 5Y7.35%
GM growth 3Y-2.67%
GM growth 5Y-2.18%
CROS.PA Yearly Profit, Operating, Gross MarginsCROS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600

More info and screens

8

2. Health

2.1 Basic Checks

CROS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CROS has about the same amount of shares outstanding.
The number of shares outstanding for CROS remains at a similar level compared to 5 years ago.
The debt/assets ratio for CROS has been reduced compared to a year ago.
CROS.PA Yearly Shares OutstandingCROS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CROS.PA Yearly Total Debt VS Total AssetsCROS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 4.95 indicates that CROS is not in any danger for bankruptcy at the moment.
CROS has a Altman-Z score of 4.95. This is amongst the best in the industry. CROS outperforms 92.75% of its industry peers.
The Debt to FCF ratio of CROS is 0.07, which is an excellent value as it means it would take CROS, only 0.07 years of fcf income to pay off all of its debts.
CROS's Debt to FCF ratio of 0.07 is amongst the best of the industry. CROS outperforms 98.55% of its industry peers.
CROS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CROS has a better Debt to Equity ratio (0.00) than 92.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 4.95
ROIC/WACC0.03
WACC7.79%
CROS.PA Yearly LT Debt VS Equity VS FCFCROS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 3.20 indicates that CROS has no problem at all paying its short term obligations.
CROS has a better Current ratio (3.20) than 76.81% of its industry peers.
CROS has a Quick Ratio of 3.20. This indicates that CROS is financially healthy and has no problem in meeting its short term obligations.
CROS has a better Quick ratio (3.20) than 79.71% of its industry peers.
Industry RankSector Rank
Current Ratio 3.2
Quick Ratio 3.2
CROS.PA Yearly Current Assets VS Current LiabilitesCROS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 405.11% over the past year.
The Earnings Per Share has been decreasing by -3.78% on average over the past years.
Looking at the last year, CROS shows a very negative growth in Revenue. The Revenue has decreased by -11.55% in the last year.
CROS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.37% yearly.
EPS 1Y (TTM)405.11%
EPS 3Y-11.3%
EPS 5Y-3.78%
EPS Q2Q%607.53%
Revenue 1Y (TTM)-11.55%
Revenue growth 3Y-11.95%
Revenue growth 5Y-10.37%
Sales Q2Q%-26.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CROS.PA Yearly Revenue VS EstimatesCROS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CROS is valuated rather expensively with a Price/Earnings ratio of 20.98.
CROS's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.84, CROS is valued a bit cheaper.
Industry RankSector Rank
PE 20.98
Fwd PE N/A
CROS.PA Price Earnings VS Forward Price EarningsCROS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CROS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 73.52
EV/EBITDA N/A
CROS.PA Per share dataCROS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

CROS has a Yearly Dividend Yield of 2.14%. Purely for dividend investing, there may be better candidates out there.
CROS's Dividend Yield is comparable with the industry average which is at 8.26.
CROS's Dividend Yield is comparable with the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.14%

5.2 History

The dividend of CROS is nicely growing with an annual growth rate of 156.54%!
Dividend Growth(5Y)156.54%
Div Incr Years0
Div Non Decr Years0
CROS.PA Yearly Dividends per shareCROS.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0.1 0.2 0.3

5.3 Sustainability

CROS pays out 19.46% of its income as dividend. This is a sustainable payout ratio.
DP19.46%
EPS Next 2YN/A
EPS Next 3YN/A
CROS.PA Yearly Income VS Free CF VS DividendCROS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M
CROS.PA Dividend Payout.CROS.PA Dividend Payout, showing the Payout Ratio.CROS.PA Dividend Payout.PayoutRetained Earnings

More info and screens

CROSSWOOD

EPA:CROS (8/19/2025, 7:00:00 PM)

10.7

+0.1 (+0.94%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners63.64%
Inst Owner ChangeN/A
Ins Owners95.04%
Ins Owner ChangeN/A
Market Cap113.74M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.14%
Yearly Dividend0.1
Dividend Growth(5Y)156.54%
DP19.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.98
Fwd PE N/A
P/S 128.09
P/FCF 73.52
P/OCF 55.87
P/B 1.36
P/tB 1.36
EV/EBITDA N/A
EPS(TTM)0.51
EY4.77%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY1.36%
OCF(TTM)0.19
OCFY1.79%
SpS0.08
BVpS7.87
TBVpS7.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.39%
ROE 6.53%
ROCE 0.26%
ROIC 0.22%
ROICexc 0.23%
ROICexgc 0.23%
OM 29.62%
PM (TTM) 615.2%
GM 65.77%
FCFM 174.21%
ROA(3y)3.13%
ROA(5y)5.13%
ROE(3y)3.87%
ROE(5y)6.65%
ROIC(3y)0.42%
ROIC(5y)0.55%
ROICexc(3y)0.43%
ROICexc(5y)0.56%
ROICexgc(3y)0.43%
ROICexgc(5y)0.56%
ROCE(3y)0.52%
ROCE(5y)0.67%
ROICexcg growth 3Y-25.56%
ROICexcg growth 5Y-29.72%
ROICexc growth 3Y-25.56%
ROICexc growth 5Y-29.71%
OM growth 3Y-15.69%
OM growth 5Y-19.63%
PM growth 3Y0.74%
PM growth 5Y7.35%
GM growth 3Y-2.67%
GM growth 5Y-2.18%
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 55.07%
Interest Coverage 3.06
Cash Conversion N/A
Profit Quality 28.32%
Current Ratio 3.2
Quick Ratio 3.2
Altman-Z 4.95
F-Score5
WACC7.79%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)39.93%
Cap/Sales(5y)36.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)405.11%
EPS 3Y-11.3%
EPS 5Y-3.78%
EPS Q2Q%607.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.55%
Revenue growth 3Y-11.95%
Revenue growth 5Y-10.37%
Sales Q2Q%-26.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.21%
EBIT growth 3Y-25.77%
EBIT growth 5Y-27.97%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y723.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y475.14%
OCF growth 3Y52.86%
OCF growth 5YN/A